MarketBeat Instant News Alerts 2 hours agoBenchmark Issues Positive Forecast for Tower Semiconductor (NASDAQ:TSEM) Stock PriceMarketBeatBenchmark upped their target price on Tower Semiconductor from $60.00 to $66.00 and gave the company a "buy" rating in a research note on Monday.NASDAQ:TSEMRead Benchmark Issues Positive Forecast for Tower Semiconductor (NASDAQ:TSEM) Stock Price2 hours agoON Semiconductor (NASDAQ:ON) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysMarketBeatNeedham & Company LLC increased their price target on ON Semiconductor from $50.00 to $58.00 and gave the company a "buy" rating in a research report on Monday.NASDAQ:ONRead ON Semiconductor (NASDAQ:ON) Stock Price Expected to Rise, Needham & Company LLC Analyst Says2 hours agoIDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysMarketBeatJPMorgan Chase & Co. lifted their price objective on IDEXX Laboratories from $550.00 to $675.00 and gave the stock an "overweight" rating in a report on Monday.NASDAQ:IDXXRead IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says2 hours agoDatadog (NASDAQ:DDOG) Price Target Raised to $160.00 at Jefferies Financial GroupMarketBeatJefferies Financial Group lifted their price objective on Datadog from $135.00 to $160.00 and gave the stock a "buy" rating in a research report on Monday.NASDAQ:DDOGRead Datadog (NASDAQ:DDOG) Price Target Raised to $160.00 at Jefferies Financial Group2 hours agoBruker (NASDAQ:BRKR) Given New $60.00 Price Target at Jefferies Financial GroupMarketBeatJefferies Financial Group decreased their price target on shares of Bruker from $70.00 to $60.00 and set a "buy" rating for the company in a report on Monday.NASDAQ:BRKRRead Bruker (NASDAQ:BRKR) Given New $60.00 Price Target at Jefferies Financial Group2 hours agoApellis Pharmaceuticals (NASDAQ:APLS) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysMarketBeatJPMorgan Chase & Co. increased their price target on Apellis Pharmaceuticals from $35.00 to $37.00 and gave the company an "overweight" rating in a research note on Monday.NASDAQ:APLSRead Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says Trending News1Microvast (MVST) to Release Earnings on Friday2CRISPR Therapeutics (NASDAQ:CRSP) Issues Quarterly Earnings Results, Beats Estimates By $0.18 EPS3Federated Hermes Inc. Has $5.93 Million Stock Position in Virgin Galactic Holdings, Inc. (NYSE:SPCE)4Lloyds Banking Group (NYSE:LYG) Raised to Neutral at JPMorgan Chase & Co.5AST SpaceMobile (ASTS) Expected to Announce Earnings on Monday6Fannie Mae (OTCMKTS:FNMA) Shares Gap Up - Here's Why7Carol B. Tome Acquires 11,682 Shares of United Parcel Service, Inc. (NYSE:UPS) Stock8Archer Aviation (NYSE:ACHR) Shares Down 2.9% - Should You Sell? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Alert Type Keywords 2 hours agoJefferies Financial Group Has Lowered Expectations for Waters (NYSE:WAT) Stock PriceMarketBeatNYSE:WATRead Jefferies Financial Group Has Lowered Expectations for Waters (NYSE:WAT) Stock Price2 hours agoWayfair (NYSE:W) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysMarketBeatNYSE:WRead Wayfair (NYSE:W) Stock Price Expected to Rise, Needham & Company LLC Analyst Says2 hours agoDA Davidson Issues Pessimistic Forecast for Builders FirstSource (NYSE:BLDR) Stock PriceMarketBeatNYSE:BLDRRead DA Davidson Issues Pessimistic Forecast for Builders FirstSource (NYSE:BLDR) Stock Price2 hours agoSwisscom (OTCMKTS:SCMWY) Reaches New 12-Month High - Still a Buy?MarketBeatOTCMKTS:SCMWYRead Swisscom (OTCMKTS:SCMWY) Reaches New 12-Month High - Still a Buy?2 hours agoAgeas (OTCMKTS:AGESY) Hits New 52-Week High - Time to Buy?MarketBeatOTCMKTS:AGESYRead Ageas (OTCMKTS:AGESY) Hits New 52-Week High - Time to Buy?2 hours agoOR Royalties (NYSE:OR) Hits New 12-Month High - Still a Buy?MarketBeatNYSE:ORRead OR Royalties (NYSE:OR) Hits New 12-Month High - Still a Buy?2 hours agoAscendis Pharma A/S (NASDAQ:ASND) Sets New 52-Week High - Time to Buy?MarketBeatNASDAQ:ASNDRead Ascendis Pharma A/S (NASDAQ:ASND) Sets New 52-Week High - Time to Buy?2 hours agoOcular Therapeutix (NASDAQ:OCUL) Reaches New 1-Year High - Should You Buy?MarketBeatNASDAQ:OCULRead Ocular Therapeutix (NASDAQ:OCUL) Reaches New 1-Year High - Should You Buy?2 hours agoCake Box (LON:CBOX) Reaches New 1-Year High - Time to Buy?MarketBeatLON:CBOXRead Cake Box (LON:CBOX) Reaches New 1-Year High - Time to Buy?2 hours agoAuction Technology Group (LON:ATG) Stock Price Down 21.7% - Time to Sell?MarketBeatLON:ATGRead Auction Technology Group (LON:ATG) Stock Price Down 21.7% - Time to Sell?2 hours agoSolGold (LON:SOLG) Stock Price Up 14% - Should You Buy?MarketBeatLON:SOLGRead SolGold (LON:SOLG) Stock Price Up 14% - Should You Buy?2 hours agoClose Brothers Group (LON:CBG) Shares Up 23.5% - Here's What HappenedMarketBeatLON:CBGRead Close Brothers Group (LON:CBG) Shares Up 23.5% - Here's What Happened2 hours agoEdgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.9% - Here's WhyMarketBeatNASDAQ:EWTXRead Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.9% - Here's Why2 hours agoStructure Therapeutics (NASDAQ:GPCR) Trading Down 4.2% - What's Next?MarketBeatNASDAQ:GPCRRead Structure Therapeutics (NASDAQ:GPCR) Trading Down 4.2% - What's Next?2 hours agoHertz Global (NYSE:HTZ) Shares Down 4.8% - Time to Sell?MarketBeatNYSE:HTZRead Hertz Global (NYSE:HTZ) Shares Down 4.8% - Time to Sell?2 hours agoPCCW (OTCMKTS:PCCWY) Stock Price Down 8.7% - Here's What HappenedMarketBeatOTCMKTS:PCCWYRead PCCW (OTCMKTS:PCCWY) Stock Price Down 8.7% - Here's What Happened2 hours agoEnergy Fuels (NYSEAMERICAN:UUUU) Trading Up 9.5% - What's Next?MarketBeatNYSEAMERICAN:UUUURead Energy Fuels (NYSEAMERICAN:UUUU) Trading Up 9.5% - What's Next?2 hours agoGinkgo Bioworks (NYSE:DNA) Stock Price Up 10.1% - Time to Buy?MarketBeatNYSE:DNARead Ginkgo Bioworks (NYSE:DNA) Stock Price Up 10.1% - Time to Buy?2 hours agoOxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down - Should You Sell?MarketBeatOTCMKTS:OXBDFRead Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down - Should You Sell?2 hours agoDucommun (NYSE:DCO) Hits New 12-Month High - What's Next?MarketBeatNYSE:DCORead Ducommun (NYSE:DCO) Hits New 12-Month High - What's Next?2 hours agoMyers Industries (NYSE:MYE) Reaches New 52-Week High - What's Next?MarketBeatNYSE:MYERead Myers Industries (NYSE:MYE) Reaches New 52-Week High - What's Next?2 hours agoOllie's Bargain Outlet (NASDAQ:OLLI) Hits New 1-Year High - Here's WhyMarketBeatNASDAQ:OLLIRead Ollie's Bargain Outlet (NASDAQ:OLLI) Hits New 1-Year High - Here's Why2 hours agoParamount Global (NASDAQ:PARAA) Stock Price Down 3.6% - Time to Sell?MarketBeatNASDAQ:PARAARead Paramount Global (NASDAQ:PARAA) Stock Price Down 3.6% - Time to Sell?2 hours agoBerkshire Hathaway (OTCMKTS:BRK.A) Stock Price Down 3.6% - Time to Sell?MarketBeatOTCMKTS:BRK.ARead Berkshire Hathaway (OTCMKTS:BRK.A) Stock Price Down 3.6% - Time to Sell? Featured Articles and OffersThis Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army ContractA new rule goes live in July — and the banks are quietly crushing itFrom American Alternative(Ad)View A new rule goes live in July — and the banks are quietly crushing it5 Stocks to Buy in August With Tremendous Upside PotentialBy Thomas Hughes | July 31, 2025View 5 Stocks to Buy in August With Tremendous Upside PotentialBitcoin and Dividends: A Winning Combo in These 3 ETFsBy Nathan Reiff | August 2, 2025View Bitcoin and Dividends: A Winning Combo in These 3 ETFsGolden Cross Alert: 3 Stocks With Serious Upside PotentialBy Chris Markoch | July 31, 2025View Golden Cross Alert: 3 Stocks With Serious Upside PotentialBanks aren’t ready for this altcoin—are you?From Crypto 101 Media(Ad)View Banks aren’t ready for this altcoin—are you?Rocket Lab Reports Next Week: Here’s What Investors Should KnowBy Ryan Hasson | August 1, 2025View Rocket Lab Reports Next Week: Here’s What Investors Should Know2 Cybersecurity Giants Nearing Big Potential BreakoutsBy Ryan Hasson | July 31, 2025View 2 Cybersecurity Giants Nearing Big Potential Breakouts Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
